Xencor, Inc. (XNCR)
33.26
-0.75
(-2.21%)
USD |
NASDAQ |
Nov 20, 16:00
33.28
+0.02
(+0.06%)
After-Hours: 20:00
Xencor EPS Diluted (Quarterly) : 0.5033 for Sept. 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 0.5033 |
| June 30, 2026 | -0.2864 |
| March 31, 2026 | -1.713 |
| December 31, 2025 | -0.0892 |
| September 30, 2025 | -0.081 |
| June 30, 2025 | -0.415 |
| March 31, 2025 | -0.6572 |
| December 31, 2024 | -0.6225 |
| September 30, 2024 | -0.7051 |
| June 30, 2024 | -1.070 |
| March 31, 2024 | -1.111 |
| December 31, 2023 | -0.3139 |
| September 30, 2023 | -0.4003 |
| June 30, 2023 | -0.3671 |
| March 31, 2023 | -1.017 |
| December 31, 2022 | -0.201 |
| September 30, 2022 | -0.5486 |
| June 30, 2022 | -0.5704 |
| March 31, 2022 | 0.3863 |
| December 31, 2021 | 1.211 |
| September 30, 2021 | -0.6888 |
| June 30, 2021 | 0.866 |
| March 31, 2021 | -0.0429 |
| December 31, 2020 | -0.2378 |
| September 30, 2020 | -0.2192 |
| Date | Value |
|---|---|
| June 30, 2020 | -0.6137 |
| March 31, 2020 | -0.1418 |
| December 31, 2019 | -0.474 |
| September 30, 2019 | -0.1805 |
| June 30, 2019 | -0.2843 |
| March 31, 2019 | 1.380 |
| December 31, 2018 | -0.3236 |
| September 30, 2018 | 0.054 |
| June 30, 2018 | -0.4646 |
| March 31, 2018 | -0.6176 |
| December 31, 2017 | 0.1528 |
| September 30, 2017 | -0.4827 |
| June 30, 2017 | -0.1652 |
| March 31, 2017 | -0.3268 |
| December 31, 2016 | -0.21 |
| September 30, 2016 | -0.20 |
| June 30, 2016 | 1.13 |
| March 31, 2016 | -0.16 |
| December 31, 2015 | 0.19 |
| September 30, 2015 | -0.25 |
| June 30, 2015 | -0.22 |
| March 31, 2015 | -0.19 |
| December 31, 2014 | -0.04 |
| September 30, 2014 | -0.20 |
| June 30, 2014 | -0.16 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Iovance Biotherapeutics, Inc. | -0.0488 |
| Ironwood Pharmaceuticals, Inc. | 0.3558 |
| UroGen Pharma Ltd. | -0.0289 |
| MeiraGTx Holdings Plc | -0.5286 |
| IDEAYA Biosciences, Inc. | -1.222 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 39.44M |
| Revenue (Quarterly) | 116.52M |
| Total Expenses (Quarterly) | 77.08M |
| Enterprise Value | 2.242B |
| Gross Profit Margin (Quarterly) | 98.08% |
| Profit Margin (Quarterly) | 33.84% |
| Earnings Yield | -4.77% |
| Normalized Earnings Yield | -4.996 |